admin

The FDA has recently issued warning letters to four companies concerning the marketing of products containing cannabidiol, alleging that claims made online concerning the health benefits of CBD violated the Federal Food, Drug and Cosmetic Act. The U.S. Food and Drug Administration (FDA) has recently issued warning letters to four companies concerning the marketing of […]

by

Child Support Awareness Month is a time when we celebrate parents who are working hard to make sure that the needs of children are met. Children thrive when family members work together to provide for their emotional and physical needs. This is especially important when a family structure changes, because regardless of the family dynamic, […]

by

According to a report by Forbes, Brightfield Group, a cannabis market research firm indicates that the international market for cannabis is projected to hit $31.4 billion by 2021. Bethany Gomez, Director of Research for Brightfield Group, explained that the U.S. market is so much larger than the rest of the international markets combined. Currently, the […]

by

TORONTO, ONTARIO–(Marketwired – Oct. 19, 2017) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs in the medical cannabis and cannabinoid pharmaceuticals sectors, today announced its results for the fiscal year ended June 30, 2017. […]

by

Cameron Masters, age 17, earned the rank of Eagle Scout following completion of his board of review on May 22, 2017. He is the son of Jeff and Stephanie Masters of Maple Valley. Cameron is a member of Boy Scouts of America Troop 711, led by Scoutmaster Wayne Dimmig and sponsored by Shepherd of the […]

by

Cameron Masters, age 17, earned the rank of Eagle Scout following completion of his board of review on May 22, 2017. He is the son of Jeff and Stephanie Masters of Maple Valley. Cameron is a member of Boy Scouts of America Troop 711, led by Scoutmaster Wayne Dimmig and sponsored by Shepherd of the […]

by

Slowly but surely, it looks like the answer to that question is yes—for medicinal purposes, at least. As marijuana becomes more accepted by the law and society at large in the United State, the major professional sports have been moving towards a more permissive and open direction towards marijuana use, albeit at a glacial pace. […]

by

This article originally appeared on VICE UK.On Wednesday, Colombian president Juan Manuel Santos announced that his country’s police force had seized 12 tons of cocaine—supposedly the most ever confiscated in one sitting in the history of the country. Police say the drugs belonged to the elusive Dario Antonio Usuga, a.k.a. “Otoniel”—head of the Gulf Clan, […]

by

JERUSALEM, Nov. 15, 2017 /PRNewswire/ — Intec Pharma LTD (NASDAQ: NTEC) (TASE: NTEC) today announced its third quarter 2017 financial results and provided a corporate update. “The third quarter was truly transformational for Intec Pharma.  We advanced our clinical development programs and are continuing to move forward with our pivotal Phase 3 trial in Parkinson’s […]

by

(MENAFN Editorial) VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSX-V:) (“Harvest One”) through its wholly owned Swiss Subsidiary Satipharm AG (“Satipharm”) is pleased to advise that results from the Phase 1 Clinical Trial undertaken by PhytoTech Therapeutics (“PTL”) in Israel using Satipharm’s proprietary GelpellR technology have been published. The […]

by

VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSX-V:HVST) (“Harvest One“) through its wholly owned Swiss Subsidiary Satipharm AG (“Satipharm“) is pleased to advise that results from the Phase 1 Clinical Trial undertaken by PhytoTech Therapeutics (“PTL“) in Israel using Satipharm’s proprietary GelpellR technology have been published. The article “Single-Dose […]

by

JERUSALEM, Nov. 15, 2017 /PRNewswire/ — Intec Pharma LTD (NASDAQ: NTEC) (TASE: NTEC) today announced its third quarter 2017 financial results and provided a corporate update. “The third quarter was truly transformational for Intec Pharma.  We advanced our clinical development programs and are continuing to move forward with our pivotal Phase 3 trial in Parkinson’s […]

by

VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSX-V:HVST) (“Harvest One“) through its wholly owned Swiss Subsidiary Satipharm AG (“Satipharm“) is pleased to advise that results from the Phase 1 Clinical Trial undertaken by PhytoTech Therapeutics (“PTL“) in Israel using Satipharm’s proprietary GelpellR technology have been published. The article “Single-Dose […]

by